Autopsy report · NCT01556152

A Clinical Trial to Study the Effects of GRC 17536 in Patients With Painful Diabetic Neuropathy (Painful Extremities Due to Peripheral Nerve Damage in Diabetic Patients)

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Due to new scientific evidence assessment, the study design was revised before the study started recruitment”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 2
Sponsor: Glenmark Pharmaceuticals Ltd. India
Sponsor type: Industry
Conditions: Painful Diabetic Neuropathy
Interventions: GRC 17536 (Medium Dose); GRC 17536 (Low Dose); Placebo
Participants: 0
Sites: 2
Countries: Germany, United Kingdom

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.